Compliance and Governance
Apply the right level of security to meet regulations
Arcot Solutions help you achieve compliance with government and industry regulations requiring strong authentication, privacy protection, identity verification and electronic document integrity. Arcot solutions support U.S. and international security standards including 3-D Secure, CardSpace, EMV, FFIEC, OATH, OpenID, SAFE, and SAML. We are PCI DSS-compliant and have achieved validation against Federal Information Processing Standard (FIPS) 140-2, Level 1, the IT security industry's "gold standard" from the U.S. National Institute of Standards and Technology (NIST).
More on specific compliance standards:
FFIEC Compliance Solution Overview
The Federal Financial Institution Examination Council (FFIEC) guidelines require online banks to adopt a variety of multifactor authentication measures to secure online access to account information and transaction functionality.
Arcot’s FFIEC solutions include RiskFort Web fraud detection and WebFort versatile authentication. You can also use the Arcot A-OK for Enterprise service to avoid having to build an authentication infrastructure on-site.
SAFE BioPharma Compliance Overview The SAFE (Signatures and Authentication for Everyone) initiative in the biopharmaceutical industry created a digital identity standard to allow companies to meet Federal requirements for signing electronic documents. The SAFE digital signature standard gives companies the ability to sign electronic documents in a tamperproof and legally enforceable way. The result is significant time savings in the approval process.
The US Food and Drug Administration (FDA) agreed to accept digital signatures for drug approval submissions. Arcot's strong authentication and digital signing technologies help you to implement the SAFE standards for digitally-signed electronic drug approval submissions to the FDA.
| “This is a significant achievement for AstraZeneca,” said Joe Waldron, Executive Director of US Drug Development Information Systems for AstraZeneca. “Digitally signed submissions will result in time efficiencies for us and for the FDA, and allow for earlier access to AstraZeneca submissions by the FDA Review Division.” |
The ease of digitally signing and electronically submitting drug approval documents can significantly accelerate a pharmaceutical company’s go-to-market process and reduce drug development costs. You can now enable digital signing in your extended network of partners, providers, investigators, and patients.
Arcot solutions for the Bio-Pharma industry:
- Arcot WebFort combined with ArcotID Secure Software Credential – A software-only, two-factor, strong authentication solution, which adds the strength of PKI to any login process while maintaining the simplicity of a username/password interface
- Arcot RegFort - A component of WebFort which simplifies your administration of credential issuance by incorporating by creating a variety of registration and issuance options, credential types and interfaces. It consolidates numerous credential-issuing systems into a single, easy to manage system.
- Arcot SignFort – Delivers secure digital signatures for your users without the need for expensive smart cards or hardware tokens. It enables employees, business partners, and customers to apply digital signatures easily from virtually any desktop.
- The Arcot Universal Client – A component of SignFort, is a single interface for deploying, managing and validating digital certificates. It enhances and simplifies your users’ experience through a consistent look-and-feel, hiding the complexity of behind-the-scenes credential management.
|
